Here we are sharing a piece of big news with you Dr Reddy’s Laboratories is an Indian multinational pharmaceutical firm based in Hyderabad. The firm was founded by Kallam Anji Reddy, previously who worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. This company stated on Thursday it has launched a wearable treatment device for drug-free management of migraine. Since the news has come on the internet it went viral on many social media platforms. Now lots of people are super curious to know about the whole information about the news. Here we have more information about the news and we will share it with you in this article.
The product named Nerivio has been endorsed by the Drug Administration (USFDA) and US Food, the Hyderabad-based drug maker stated in a regulatory filing. The drug market stated in the press release “Nerivio is a first and only USFDA authorised device to use Remote Electrical Neuromodulation (REN) to control and treat migraine. Thousands of people are curious to know about the whole information about the news. You are on the right page for more information about the news, so please read the complete article.
Dr Reddy’s CEO of Markets MV Ramana stated ” Nerivio rollout marks our entrance into digital therapeutics. It is an area that has been seeing growing adoption by physicians as well as patients because of its possibility to reduce dependence on specific drugs in chronic or hard-to-treat diseases,”.Now lots of people are very interested in knowing about what is Nerivio. Swipe up the next page for more information about the news.
What is Nerivio?
Dr Reddy’s Laboratories stated that Nerivio is a prescription-based non-invasive device planned for acute and prophylactic (preventive) treatment of migraine.
Who can use Nerivio?
The medicine maker stated the device is for people aged 12 years and above. Nerivio is suitable for a wide range of patients, including those who prefer drug-free options, people with contraindications to drugs or poor medication patience, sensitive folks such as adolescents, ladies of weak age groups and patients at risk of medication overuse
headaches.”
How efficient it is and Nerivio’s cost
Dr Reddy stated Nerivio confirmed efficacy in not only treating relief of pain but also associated signs in migraine such as nausea, vomiting etc. It is shown to decrease the need for drugs utilised for acute treatment in close to nine out of 10 patients”. Nerivio is priced at ₹14,000-16,000. Here we have shared all the information which we had. Stay tuned to us for more updates.